Apellis Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsApellis Pharmaceuticals

Apellis Pharmaceuticals(APLS)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Empaveli	Pegcetacoplan	2021-05-14	2026-2038	Paroxysmal hemoglobinuria
Syfovre	Pegcetacoplan	2023-02-17	2026-2038	Paroxysmal hemoglobinuria

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

vascular diseases

,

thrombotic microangiopathies

,

hemolytic anemia autoimmune

,

paroxysmal hemoglobinuria

,

,

,

liver neoplasms

,

neoplasm metastasis

healthy volunteers/patients

,

,

pheochromocytoma

,

neuroendocrine tumors

,

,

meningeal carcinomatosis

,

,

laryngeal neoplasms

,

pancreatic ductal carcinoma

,

head and neck neoplasms

,

squamous cell neoplasms

,

transitional cell carcinoma

,

malignant pleural effusion

,

fallopian tube neoplasms

,

small cell carcinoma

,

gastrointestinal neoplasms

,

dna repair-deficiency disorders

,

urinary bladder neoplasms

,

salivary gland neoplasms

,

,

,

radiation injuries

,

radiation effects

,

germ cell and embryonal neoplasms

,

peritoneal neoplasms

,

,

pleural effusion

,

,

,

residual neoplasm

,

breast neoplasms

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

prostatic neoplasms

,

,

,

neoplasm metastasis

,

,

small cell lung carcinoma

,

,

,

,

,

rheumatoid arthritis

,

castration-resistant prostatic neoplasms

,

triple negative breast neoplasms

,

ovarian neoplasms

,

,

major depressive disorder

,

depressive disorder

,

,

gastroesophageal reflux

,

peptic esophagitis

,

,

colorectal neoplasms

,

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

endometrial neoplasms

,

,

renal cell carcinoma

,

urologic neoplasms

,

ovarian epithelial carcinoma

,

neoplasms by site

,

,

,

,

kidney diseases

,

,

cardiovascular diseases

,

pancreatic neoplasms

,

hypersensitivity

,

stomach neoplasms

,

sickle cell anemia

,

brain neoplasms

,

,

,

opioid-induced constipation

,

,

hypercholesterolemia

,

hepatocellular carcinoma

,

liver neoplasms

,

hereditary breast and ovarian cancer syndrome

,

,

chronic renal insufficiency

,

,

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

kidney neoplasms

,

,

zollinger-ellison syndrome

,

,

peptic ulcer hemorrhage

,

,

,

chronic obstructive pulmonary disease

,

obstructive lung diseases

,

,

anxiety disorders

,

,

venous thrombosis

,

pulmonary embolism

,

plexiform neurofibroma

,

neurofibromatosis 1

,

neurofibromatoses

,

,

unknown primary neoplasms

,

respiratory insufficiency

,

myocardial infarction

,

coronary artery disease

,

bile duct neoplasms

,

cholangiocarcinoma

,

biliary tract neoplasms

,

,

gallbladder neoplasms

,

respiratory syncytial virus infections

,

uterine neoplasms

,

non-small-cell lung carcinoma

,

,

respiratory tract diseases

,

respiratory tract neoplasms

,

bronchogenic carcinoma

,

thoracic neoplasms

,

bronchial neoplasms

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use